DURECT (NASDAQ:DRRX – Get Free Report) is expected to post its quarterly earnings results before the market opens on ...

Inventiva (NASDAQ:IVA – Get Free Report) is projected to issue its quarterly earnings data before the market opens on ...

It's hard to overstate how much demand could be out there for effective weight management drugs. The global anti-obesity drug ...

Resmetirom is a medication approved by the FDA to treat adults with noncirrhotic non-alcoholic steatohepatitis (NASH) with ...

The advent of artificial intelligence (AI) in healthcare is creating waves of innovation, transforming traditional medical practices. One of the ...